Novel 18F and 64Cu labelled targeted nanoparticles for molecular positron emission tomography: A means for early and sensitive detection of thrombosis, inflammation and vulnerable, rupture-prone atherosclerotic plaques

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1029249

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The aim of this project is to develop novel targeted positron emission tomography imaging agents that seek out specific markers for various states of cardiovascular disease. These agents would provide a method for detecting the presence and level of atherosclerosis and thrombotic events. The targeted nanoparticles may provide a unique opportunity to detect very early plaques and the vulnerability of existing plaques.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $572,931.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nanomedicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody | atherosclerosis | imaging | inflammation | inflammatory arthritis | molecular imaging | nanotechnology | plaque rupture | positron emission tomography (PET) | thrombosis

Related Links